{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:38:26Z","timestamp":1787499506711,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-026-01471-5","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:28:36Z","timestamp":1773311316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies"],"prefix":"10.1038","volume":"16","author":[{"given":"Elvira","family":"Umyarova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Denlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7603-6454","authenticated-orcid":false,"given":"Timothy","family":"Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8568-4522","authenticated-orcid":false,"given":"Marcos","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-3457","authenticated-orcid":false,"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"1471_CR1","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41571-023-00754-1","volume":"20","author":"KM Cappell","year":"2023","unstructured":"Cappell KM, Kochenderfer JN. Long-term outcomes following CAR T cell therapy: what we know so far. Nat Rev Clin Oncol. 2023;20:359\u201371.","journal-title":"Nat Rev Clin Oncol"},{"key":"1471_CR2","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jaad.2016.06.062","volume":"75","author":"CB Rubin","year":"2016","unstructured":"Rubin CB, Elenitsas R, Taylor L, Lacey SF, Kulikovskaya I, Gupta M, et al. Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy. J Am Acad Dermatol. 2016;75:1054\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1471_CR3","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jaad.2021.07.017","volume":"87","author":"KB Nusbaum","year":"2022","unstructured":"Nusbaum KB, Dulmage B, Choi JN, Jaglowski SM, Korman AM. Cutaneous manifestations of chimeric antigen receptor T-cell therapy: An introduction for dermatologists. J Am Acad Dermatol. 2022;87:597\u2013604.","journal-title":"J Am Acad Dermatol"},{"key":"1471_CR4","doi-asserted-by":"publisher","first-page":"1035.e1","DOI":"10.1016\/j.jtct.2024.06.024","volume":"30","author":"R Storgard","year":"2024","unstructured":"Storgard R, Dusza S, Shouval R, Scordo M, Markova A. Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System. Transplant Cell Ther. 2024;30:1035.e1\u2013.e7.","journal-title":"Transplant Cell Ther"},{"key":"1471_CR5","unstructured":"Food US, Administration D. ABECMA (idecabtagene vicleucel) package insert. Silver Spring, MD: Bristol-Myers Squibb Company; 2021."},{"key":"1471_CR6","unstructured":"Food US. Administration D. YESCARTA (axicabtagene ciloleucel) package insert. Silver Spring, MD: Kite Pharma, Inc.; 2017."},{"key":"1471_CR7","unstructured":"Administration USFD. KYMRIAH (tisagenlecleucel) package insert. Silver Spring, MD: Novartis Pharmaceuticals Corporation; 2017."},{"key":"1471_CR8","unstructured":"Administration USFD. TECARTUS (brexucabtagene autoleucel) package insert. Silver Spring, MD: Kite Pharma, Inc.; 2020."},{"key":"1471_CR9","unstructured":"Administration USFD. BREYANZI (lisocabtagene maraleucel) package insert. Silver Spring, MD: Bristol-Myers Squibb; 2021."},{"key":"1471_CR10","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1111\/jdv.18892","volume":"37","author":"G Fiorillo","year":"2023","unstructured":"Fiorillo G, Toso F, Cortese A, Piscazzi F, Bressan A, Bramanti S, et al. Cutaneous toxicity of CAR T-cell therapy: Case report of a bullous life-threatening reaction. J Eur Acad Dermatol Venereol. 2023;37:e729\u2013e31.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01471-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01471-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01471-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:28:43Z","timestamp":1773311323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01471-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1471"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01471-5","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}